Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Liver Transplantation: later-stage trial registry
4 of 13 indexed Liver Transplantation trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 4 currently recruiting · #1,315 of 28,707 conditions by registered trial count
Liver Transplantation: 13 US clinical trials tracked, 4 recruiting.
Liver Transplantation is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Astellas Pharma Europe, running 1 of these trials.
Enrollment posture brief
Registry condition liver-transplantation
OPEN 4 | RECR 31% | LATE 4 | EARLY 2 | RANK #1315 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Decompensated Heart Failure (31% recruiting · 13 trials)
Liver Transplantation lists 4 open slots (31% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Liver Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Liver Transplantation is recruiting below its size-band peers.
4 of 13 indexed trials (30.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Liver Transplantation trials is spread across many organizations.
Astellas Pharma Europe accounts for 1 of 13 trials (7.7%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical Liver Transplantation enrolment sits around 120 participants.
Median target enrolment is 120 among the 13 trials that report a genuine target (sentinel values excluded). 6 of those (46.2%) plan for fewer than 100 participants.
-
Liver Transplantation research is mostly interventional.
10 interventional and 3 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
HOPE Against Cancer Recurrence in HCC
Philipp Dutkowski
NCT06717919
Mediterranean Diet Post-liver Transplantation
Mayo Clinic
NCT04672863
Reducing Pain With Methadone and Ketamine in Liver Transplant
Lahey Clinic
NCT06868589
Immune Tolerance Induction After Liver Transplantation
University of California, Los Angeles
NCT07269041
Molecular Assessment and Profiling of Liver Transplant Recipients
CareDx
NCT04793360
Social & Contextual Impact on Children Undergoing Liver Transplantation
University of California, San Francisco
NCT04551742
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
Organ Recovery Systems
NCT05574361
Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation
Koji Hashimoto
NCT04023773
Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant
Astellas Pharma Europe
NCT02118896
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Novartis Pharmaceuticals
NCT01888432
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01638559
Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant
University of Miami
NCT01216722
Hemodynamic Measurements During Liver Transplantation
Washington University School of Medicine
NCT00682110
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Liver Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Liver Transplantation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Liver Transplantation page
13 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Liver Transplantation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Astellas Pharma Europe sponsors the most Liver Transplantation trials on record, review their full trial history before evaluating a specific study. See Astellas Pharma Europe's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Liver Transplantation condition card totals 13 registered trials; most-linked intervention Immunosuppression withdrawal; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.